DXCM241220C77000
- 1.50
- +0.05+3.45%
DexCom Newsroom
Dexcom's Over-the-counter Glucose Monitor Now Offers Users an AI Summary of How Sleep, Meals and More Impact Sugar Levels
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
Express News | Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (Cgm) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 Cgm
Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM
Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Worst Performing Stocks for Tax Loss Selling – Wolfe
Peering Into DexCom's Recent Short Interest
The Nasdaq 100 is about to adjust, and these 11 companies may see a 50% increase in upside potential.
As the annual adjustment of the NASDAQ 100 Index approaches, a group of potential stocks is preparing to make their debut. This adjustment not only brings prestige to these companies but may also trigger a large-scale inflow of capital, further driving up stock prices.
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher
TNDM Stock to Gain From T:slim X2 With Dexcom G7 Launch in Canada
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Why DexCom, Inc. (NASDAQ:DXCM) Looks Like A Quality Company
Nephron Research Adjusts Price Target on DexCom to $125 From $145
DexCom Is Maintained at Buy by Citigroup
10 BofA U.S. Options Overwriting Ideas
Unusual Options Activity: ACI, FTI and Others Attract Market Bets, ACI V/OI Ratio Reaches 75.0
EST Dec 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
DexCom Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94
Express News | Dexcom Inc : Citigroup Raises Target Price to $91 From $85
Express News | Dexcom, Inc. : Wells Fargo Raises Target Price to $94 From $90